Silber, J H <br/><br/>
Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors.  [electronic resource] 

 -  American heart journal  Oct 2001 
 - 577-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1067/mhj.2001.118115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Algorithms<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Anthracyclines--adverse effects<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Double-Blind Method<br/>Enalapril--adverse effects<br/>Female<br/>Heart Diseases--chemically induced<br/>Heart Function Tests<br/>Humans<br/>Infant<br/>Male<br/>Neoplasms--drug therapy<br/>Placebos<br/>Research Design--standards<br/>Statistics, Nonparametric